AbstractBackgroundThere are no data available on specific causes of death from randomized trials that have compared coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI).ObjectivesThe purpose of this study was to investigate specific causes of death, and its predictors, after revascularization for complex coronary disease in patients.MethodsAn independent Clinical Events Committee consisting of expert physicians who were blinded to the study treatment subclassified causes of death as cardiovascular (cardiac and vascular), noncardiovascular, or undetermined according to the trial protocol. Cardiac deaths were classified as sudden cardiac, related to myocardial infarction (MI), and other cardiac deaths.ResultsIn...
Introduction The primary end points of randomized clinical trials evaluating the outcome of therapeu...
Background: There is limited information on the incidence and prognostic impact of new-onset atrial ...
Aims: To investigate the impact of established cardiovascular disease (CVD) on 10-year all-cause dea...
AbstractBackgroundThere are no data available on specific causes of death from randomized trials tha...
BACKGROUND There are no data available on specific causes of death from randomized trials that have ...
Background: Numerous randomised trials have compared coronary artery bypass grafting (CABG) with per...
ObjectivesThis study sought to analyze stroke rates in the SYNTAX (Synergy Between Percutaneous Coro...
ObjectivesWe sought to examine the effect of revascularization with coronary artery bypass grafting ...
Purpose: To ascertain the most appropriate treatment for chronic, stable, coronary artery disease (C...
Background In chronic coronary syndromes, myocardial ischemia is associated with a greater risk of d...
Background—Prior studies suggest that most deaths in patients undergoing percutaneous coronary inter...
Background—Prior studies suggest that most deaths in patients undergoing percutaneous coronary inter...
BackroundThe hospital cardiac arrest (ACEH) represent the leading cause of death worldwide. Despite ...
BACKGROUND Long-term outcomes after percutaneous coronary intervention (PCI) with contemporary drug...
Introduction The primary end points of randomized clinical trials evaluating the outcome of therapeu...
Introduction The primary end points of randomized clinical trials evaluating the outcome of therapeu...
Background: There is limited information on the incidence and prognostic impact of new-onset atrial ...
Aims: To investigate the impact of established cardiovascular disease (CVD) on 10-year all-cause dea...
AbstractBackgroundThere are no data available on specific causes of death from randomized trials tha...
BACKGROUND There are no data available on specific causes of death from randomized trials that have ...
Background: Numerous randomised trials have compared coronary artery bypass grafting (CABG) with per...
ObjectivesThis study sought to analyze stroke rates in the SYNTAX (Synergy Between Percutaneous Coro...
ObjectivesWe sought to examine the effect of revascularization with coronary artery bypass grafting ...
Purpose: To ascertain the most appropriate treatment for chronic, stable, coronary artery disease (C...
Background In chronic coronary syndromes, myocardial ischemia is associated with a greater risk of d...
Background—Prior studies suggest that most deaths in patients undergoing percutaneous coronary inter...
Background—Prior studies suggest that most deaths in patients undergoing percutaneous coronary inter...
BackroundThe hospital cardiac arrest (ACEH) represent the leading cause of death worldwide. Despite ...
BACKGROUND Long-term outcomes after percutaneous coronary intervention (PCI) with contemporary drug...
Introduction The primary end points of randomized clinical trials evaluating the outcome of therapeu...
Introduction The primary end points of randomized clinical trials evaluating the outcome of therapeu...
Background: There is limited information on the incidence and prognostic impact of new-onset atrial ...
Aims: To investigate the impact of established cardiovascular disease (CVD) on 10-year all-cause dea...